28 Jun, 2024 The evolving landscape of patent term extensions By Rebecca Lawrence Petros Nafpliotis Part 1: Supplementary Protection Certificates – harmonisation Following the European elections earlier this month, innovator’s eyes are...
31 May, 2023 Expert witnesses in Australian patent litigation - Recent federal court decisions reinforce the need to choose your expert witnesses carefully By Nicholas Tyacke Robynne Sanders Greg Bodulovic Alexandra de Zwart Jordan Davis +2 more... Show less The role of the expert witness is often crucial in Australian patent litigation, especially where the invention in question is...
17 Apr, 2023 Plausibility of inventions: the decision of the EPO Enlarged Board of Appeal in G 2/21 By Massimiliano Tiberio Introduction On March 23rd, 2023, the Enlarged Board of Appeal of the EPO issued the long-awaited decision concerning the concept of...
02 Sep, 2022 Expedite patent examination for foreign applicants in Brazil By Domiciano Sá The Brazilian Patent and Trademark Office (BRPTO) efforts to reduce the patent backlog is generating positive results despite the...
22 Aug, 2022 UPC on the go – Practical advice on the Unified Patent Court (episode 2) By Guialtiero Dragotti Language has been the biggest hurdle in the Unified Patent Court's creation since it was first mooted over 40 years ago. In the latest...
17 May, 2022 Patent term extensions and infringement proceedings in Australia, and the standing of an exclusive licensee By Nicholas Tyacke Alexandra de Zwart Sarah McKenzie For pharmaceutical companies, patent term extensions (PTEs) remain a fundamental means of compensating them for the erosion of the terms...
28 Mar, 2022 Patent term extensions in Australia – further challenges for pharmaceutical patentees By Nicholas Tyacke Alexandra de Zwart Sarah McKenzie Patent term extensions (PTEs) in Australia have been a hot topic over the past year. On Friday, things got a lot hotter for patentees...
03 Mar, 2022 A new dawn for the UPC and the Unitary Patent By Markus Gampp Sarah Turner In Europe, the unitary patent and the Unified Patent Court (UPC) have moved another step closer since Austria’s deposit of its...
17 Oct, 2021 Patent term extensions in Australia – What if the patent covers more than one approved product? By Nicholas Tyacke Alexandra de Zwart In its second significant recent decision addressing patent term extensions in Australia, the Federal Court of Australia, in Merck Sharp...
20 Aug, 2021 Patent term extensions in Australia - A significant victory for pharmaceutical patentees By Nicholas Tyacke Summary In a significant victory for pharmaceutical patentees, the Federal Court in Ono Pharmaceutical Co. Ltd v Commissioner of Patents...
05 Aug, 2021 Australian Court determines that an Artificial Intelligence system can be an inventor for the purposes of patent law By Nicholas Tyacke Alexandra de Zwart Artificial Intelligence (AI) and machine learning are increasingly used in the life sciences industry for research and drug discovery,...
20 Jun, 2021 Patent term extensions in Australia - A significant victory for pharmaceutical patentees By Nicholas Tyacke Ben Mawby Sarah Parkin Summary In a significant victory for pharmaceutical patentees, the Federal Court in Ono Pharmaceutical Co. Ltd v Commissioner of Patents...
12 May, 2021 Australian patent box tax incentive announced in Federal Budget By Nicholas Tyacke Alexandra de Zwart Holly Yuan Greg Bodulovic Robynne Sanders +2 more... Show less The 2021-2022 Australian Federal Budget was unveiled last night (11 May 2021). Deemed the ‘COVID-19 Recovery Budget’, it includes a...
07 Apr, 2021 Patent eligibility in bioinformatics: Federal Circuit affirms rejection of computerized haplotype phasing claims By John McDermott Susan Krumplitsch In a pair of opinions issued in March, the Federal Circuit affirmed two Patent Trial and Appeal Board determinations that...
27 Jan, 2021 Is a chocolate teapot sufficient? By Jim McDonnell It is always interesting to see how a Supreme Court judgment is applied in later cases, especially the first few times, and the High...
06 Mar, 2018 Pharma and biotech legal developments - C5 conference report By DLA Piper I spent two fascinating days at the C5 Pharma and biotech conference last week. Some of the more interesting takeaways: in determining...